Access in South Korea

Regulatory framework

South Korea's MFDS permits named-patient import under strict physician and institutional controls.

Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.

Typical timeline

For patients in South Korea requesting a specialty drug through Reserve Meds, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

1. Patient or physician submits a request with drug name and indication.
2. We verify clinical appropriateness and document eligibility.
3. Treating physician issues prescription and clinical justification.
4. Country-specific regulatory documentation is prepared and submitted.
5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
6. Drug ships cold-chain to destination physician or hospital pharmacy.
7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from South Korea